The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s circulating tumor cells market report forecasts the circulating tumor cells market size to grow to $16.70 Billion by 2027, with a CAGR (compound annual growth rate) of more than 11%.

Learn More On The Circulating Tumor Cells Market Report 2023 – https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Circulating Tumor Cells Market Size Forecast
The global circulating tumor cells market is expected to grow from $9.52 billion in 2022 to $10.71 billion in 2023 at a compound annual growth rate (CAGR) of 12.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global circulating tumor cells market size is expected to grow to $16.70 billion in 2027 at a CAGR of 11.7%.

North America held the largest circulating tumor cells market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Circulating Tumor Cells Market Driver ­– Growth In The Incidence Of Cancer
According to the World Health Organization (WHO), a Switzerland-based international agency responsible for international public health, there were approximately 19.29 million new cancer cases in 2020, and the number of cancer cases over a five-year period is estimated to be 50.55 million. As a result, the rising cancer incidence is propelling the circulating tumour cells market forward.

Request for A Sample Of The Global Circulating Tumor Cells Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Key Circulating Tumor Cells Market Trend – Product Innovations
To strengthen their market position, major companies in the circulating tumour cells market are focusing on developing innovative products. Menarini Silicon Biosystems, an Italian company that specialises in liquid biopsy and single-cell technologies, for example, launched the new CellMag CTC Epithelial Cell kit in February 2021. The kit makes manual immuno-magnetic enrichment and staining of rare CTCs easier with ferrofluid technology (circulating tumour cells). It is a low-cost and simple protocol for liquid biopsy labs that allows for sample preparation standardisation.

Circulating Tumor Cells Market Segment
1) By Product: Kits and Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical or Liquid Biopsy, Research

Circulating Tumor Cells Market Major Players and Strategies
Major players in the circulating tumor cells market are Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec, Menarini Silicon Biosystems, Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, and LineaRx Inc.

Agilent Technologies Inc., a US-based provider of laboratory workflow software, instruments, and services, acquired Resolution Bioscience Inc. for an undisclosed sum in April 2021. Agilent expands and strengthens its capabilities in cancer diagnostics and provides innovative technology to the medicine market as a result of this acquisition. Resolution Bioscience, Inc. is a company based in the United States that develops next-generation sequencing-based oncology solutions.

The Circulating Tumor Cells Global Market Report 2023 covers regional data on circulating tumor cells market size, circulating tumor cells market trends and drivers, opportunities, strategies, and circulating tumor cells market competitor analysis. The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Circulating tumour cells are solid tumor-derived cells that have shed from the primary tumour and have entered the bloodstream. They are used to help with cancer diagnosis and prognosis.

View More Reports Related To The Circulating Tumor Cells Market –
Tumor Ablation Therapy Devices Global Market Report 2023
Tumor Embolization Devices Global Market Report 2023
Cardiovascular Surgery Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: